Novartis and Qualcomm are to develop a 'smart' COPD inhaler to allow patients to ... plans by Novartis's rivals in the respiratory field, GlaxoSmithKline (GSK) and Boehringer Ingelheim (BI ...

The fires that have engulfed Los Angeles cap the hottest decade in history. Each year in the last ten was record-warm, but 2024 was the warmest ever recorded. Last year, Earth was 1.6°C hotter ...

GlaxoSmithKline is eyeing another indication for its Nucala (mepolizumab) biologic drug after a phase 3 trial in inflammation caused by nasal polyps hit its targets, bringing it into competition ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

GSK said depemokimab would be exciting in terms of transition from Nucala. GSK says another product, gepotidacin, is the first in a new class of oral antibiotics for uUTI in over twenty years.

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

I’ve walked the streets of LA, its history as vivid as its fires. Now, the city burns, and its dreams smoulder in the ash Joan Didion, that most perceptive observer of Los Angeles life, was ...

GSK has agreed to buy US biopharmaceutical business IDRx in a deal worth up to $1.15billion (£1billion). Under the agreement, GSK will pay $1billion upfront to acquire the Massachusetts-based ...

NOAA has declared that a La Niña is underway. This cool weather event is likely to be shorter and weaker than usual, but will still affect global weather and climate. When you purchase through ...

Just a couple of years ago, herbal inhalers were seen as something only aunties and uncles use. You can almost picture a caricature of them taking comically deep whiffs to clear their nasal packages, ...

UK pharma major GSK (LSE: GSK) is to acquire IDRx, a Boston, USA-based, clinical-stage biopharma developing precision therapeutics for the treatment of gastrointestinal stromal tumors (GIST). Under ...